|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kohlberger PD, Breitenecker F, Kaider A,
Lösch A, Gitsch G, Breitenecker G and Kieback DG: Modified
truecolor computer-assisted image analysis versussubjective scoring
of estrogen receptor expression in breast cancer: A comparison.
Anticancer Res. 19:2189–2193. 1999.PubMed/NCBI
|
|
3
|
Kikuchi A: Regulation of beta-catenin
signaling in the Wnt pathway. Biochem Biophys Res Commun.
268:243–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mauro L, Pellegrino M, Giordano F, Ricchio
E, Rizza P, De Amicis F, Catalano S, Bonofiglio D, Panno ML and
Andò S: Estrogen receptor-α drives adiponectin effects on cyclin D1
expression in breast cancer cells. FASEB J. 29:2150–2160. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo J, Chen YL and Xu H: Expression of
β-catenin, cyclin D1 and ERα in breast cancer. Shi Yong Yu Fang Yi
Xue. 17:1502–1504. 2010.(In Chinese).
|
|
6
|
Kuiper GG, Enmark E, PeltoHuikko M,
Nilsson S and Gustafsson JA: Cloning of a novel receptor expressed
in rat prostate and ovary. Proc Natl Acad Sci USA. 93:5925–5930.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Speirs V, Parkes AT, Kerin MJ, Walton DS,
Carleton PJ, Fox JN and Atkin SL: Coexpression of estrogen receptor
α and β: Poor progonostic factors in human breast cancer. Cancer
Res. 59:525–528. 1999.PubMed/NCBI
|
|
8
|
Speirs V, Adams IP, Walton DS and Atkin
SL: Identification of wild-type and exon 5 deletion variants of
estrogen receptor beta in normal human mammary gland. J Clin
Endocrinol Metab. 85:1601–1605. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Howe LR and Brown AM: Wnt signaling and
breast cancer. Cancer Biol Ther. 3:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bala S and Peltomäki P: CYCLIN D1 as a
genetic modifier in hereditary non polyposis colorectal cancer.
Cancer Res. 61:6042–6045. 2001.PubMed/NCBI
|
|
11
|
Lim SC and Lee MS: Significance of
E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Oncol Rep. 9:915–928. 2002.PubMed/NCBI
|
|
12
|
Lin SY, Xia W, Wang JC, et al:
Beta-catenin, a novel prognostic marker for breast cancer: Its
roles in cyclin D1 expression and cancer progression. Proc Natl
Acad Sci USA. 97:4262–4266. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brabletz T, Jung A, Reu S, et al: Variable
beta-catenin expression in colorectal cancers indicates tumor
progression driven by the tumor environment. Proc Natl Acad Sci
USA. 98:10356–10361. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paola C, Anna P, Marina R, Gnesi E,
Baldini E and Bevilacqua G: Cyclin D1 expression in node positive
(N+) and node-negative (N-) infiltrating human mammary carcinomas.
Int J Cancer. 84:139–144. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ozaki S, Ikeda S, Ishizaki Y, et al:
Alterations and correlations of the components in the Wnt signaling
pathway and its target genes in breast cancer. Oncol Rep.
14:1437–1443. 2005.PubMed/NCBI
|
|
16
|
Yang JF, Chen SL, Liu ZH and Zhang Y:
Correlation among expression of E-cadherin, beta-catenin, and
cyclin D1 in breast cancers. Ai Zheng. 23:799–802. 2004.(In
Chinese). PubMed/NCBI
|
|
17
|
Lazennec G, Bresson D, Lucas A, Chauveau C
and Vignon F: ER beta inhibits proliferation and invasion of breast
cancer cells. Endocrinology. 142:4120–4130. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
CastroRivera E, Samudio I and Safe S:
Estrogen regulation of cyclin D1 gene expression in ZP-75 breast
cancer cells involves multiple enhancer elements. J Biol Chem.
276:30853–30861. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ravikumar G and Ananthamurthy A: Cyclin D1
expression in ductal carcinoma of the breast and its correlation
with other prognostic parameters. J Cancer Res Ther. 10:671–675.
2014.PubMed/NCBI
|
|
20
|
Zwijsen R, Wientjens E, Klompmaker R, van
der Sman J, Bernards R and Michalides RJ: CDK-independent
activation of estrogen receptor by cyclin D1. Cell. 88:405–415.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Musgrove EA: Wnt signaling via the
epidermal growth factor receptor: A role in breast cancer? Breast
Cancer Res. 6:65–68. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakopoulou L, Mylona E, Papadaki I,
Kavantzas N, Giannopoulou I, Markaki S and Keramopoulos A: Study of
phospho-beta-catenin subcellular distribution in invasive breast
carcinomas in relation to their phenotype and the clinical outcome.
Mod Pathol. 19:556–563. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
López-Knowles E, Zardawi SJ, McNeil CM, et
al: Cytoplasmic localization of beta-catenin is a marker of poor
outcome in breast cancer patients. Cancer Epidemiol Biomarkers
Prev. 19:301–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chung GG, Zerkowski MP, Ocal IT, et al:
beta-Catenin and p53 analyses of a breast carcinoma tissue
microarray. Cancer. 100:2084–2092. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gillett C, Smith P, Gregory W, Richards M,
Millis R, Peters G and Barnes D: Cyclin D1 and prognosis in human
breast cancer. Int J Cancer. 69:92–99. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Steeg PS and Zhou Q: Cyclins and breast
cancer. Breast Cancer Res Treat. 52:17–28. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Diana M and Barnes CEG: Cyclin D1 in
breast cancer. Acta Oncology. 24:4211995.
|
|
28
|
Bates S, Parry D, Bonetta L, Vousden K,
Dickson C and Peters G: Absence of cyclin D/CDK complexes in cells
lacking functional retinoblastoma protein. Oncogene. 9:1633–1640.
1994.PubMed/NCBI
|
|
29
|
Quintayo MA, Munro AF, Thomas J, et al:
GSK3β and cyclin D1 expression predicts outcome in early breast
cancer patients. Breast Cancer Res Treat. 136:161–168. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peurala E, Koivunen P, Haapasaari KM,
Bloigu R and Jukkola-Vuorinen A: The prognostic significance and
value of cyclin D1, CDK4 and p16 in human breast cancer. Breast
Cancer Res. 15:R52013. View
Article : Google Scholar : PubMed/NCBI
|
